BACKGROUND: Prescription monitoring programs scrutinize the prescribing of controlled substances to diminish the utilization of multiple prescribers (aka. "doctor shopping"). The use of multiple prescribers is not a problem per se and can be legitimate, as when the patient's regular physician is not available or a concurrent painful condition is being cared for by a different practitioner. PURPOSE: The primary objective of this study was to determine if those patients who used a few prescribers (two to five) in a 1-year period were distinguishable from those who used only one prescriber. METHODS: We performed a secondary data analysis of the California Prescription Monitoring Program, the Controlled Substance Utilization Review and Evaluation System, by using data collected during 1999-2007. RESULTS: The group who used a few providers (two to five) differed substantially from those who visited one provider over a 1-year period. However, the dissimilarity did not suggest that these patients were more prone to the abuse of opioids. CONCLUSIONS: The decision not to investigate patients who visit a low number of multiple prescribers (two to five) appears to be justifiable. If the number of providers in a given period of time is used to determine if a patient should be challenged as being a "doctor shopper," cutoffs with high specificity (low false-positive rates) should be chosen. Further epidemiologic research is needed to determine the association of the number of prescribers and misuse and/or abuse of opioids.
BACKGROUND: Prescription monitoring programs scrutinize the prescribing of controlled substances to diminish the utilization of multiple prescribers (aka. "doctor shopping"). The use of multiple prescribers is not a problem per se and can be legitimate, as when the patient's regular physician is not available or a concurrent painful condition is being cared for by a different practitioner. PURPOSE: The primary objective of this study was to determine if those patients who used a few prescribers (two to five) in a 1-year period were distinguishable from those who used only one prescriber. METHODS: We performed a secondary data analysis of the California Prescription Monitoring Program, the Controlled Substance Utilization Review and Evaluation System, by using data collected during 1999-2007. RESULTS: The group who used a few providers (two to five) differed substantially from those who visited one provider over a 1-year period. However, the dissimilarity did not suggest that these patients were more prone to the abuse of opioids. CONCLUSIONS: The decision not to investigate patients who visit a low number of multiple prescribers (two to five) appears to be justifiable. If the number of providers in a given period of time is used to determine if a patient should be challenged as being a "doctor shopper," cutoffs with high specificity (low false-positive rates) should be chosen. Further epidemiologic research is needed to determine the association of the number of prescribers and misuse and/or abuse of opioids.
Authors: Nathaniel P Katz; Edgar H Adams; James C Benneyan; Howard G Birnbaum; Simon H Budman; Ronald W Buzzeo; Daniel B Carr; Theodore J Cicero; Douglas Gourlay; James A Inciardi; David E Joranson; James Kesslick; Stephen D Lande Journal: Clin J Pain Date: 2007-02 Impact factor: 3.442
Authors: Beatrix M Schieffer; Quyhn Pham; Jennifer Labus; Ariel Baria; Walter Van Vort; Philip Davis; Frederick Davis; Bruce D Naliboff Journal: J Pain Date: 2005-09 Impact factor: 5.820
Authors: Stephen T Parente; Susan S Kim; Michael D Finch; Lisa A Schloff; Thomas S Rector; Raafat Seifeldin; J David Haddox Journal: Am J Manag Care Date: 2004-11 Impact factor: 2.229
Authors: Ajay D Wasan; Stephen F Butler; Simon H Budman; Christine Benoit; Kathrine Fernandez; Robert N Jamison Journal: Clin J Pain Date: 2007-05 Impact factor: 3.442
Authors: Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi Journal: JAMA Date: 2008-12-10 Impact factor: 56.272
Authors: Barth L Wilsey; Scott M Fishman; Alexander Tsodikov; Christine Ogden; Ingela Symreng; Amy Ernst Journal: Pain Med Date: 2008-02-05 Impact factor: 3.750
Authors: Alai Tan; Holly M Holmes; Yong-Fang Kuo; Mukaila A Raji; James S Goodwin Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05-24 Impact factor: 6.053
Authors: Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson Journal: Drug Saf Date: 2015-06 Impact factor: 5.606
Authors: Joanne E Brady; Hannah Wunsch; Charles DiMaggio; Barbara H Lang; James Giglio; Guohua Li Journal: Public Health Rep Date: 2014 Mar-Apr Impact factor: 2.792
Authors: Kimberly A Gudzune; Sara N Bleich; Thomas M Richards; Jonathan P Weiner; Krista Hodges; Jeanne M Clark Journal: Obesity (Silver Spring) Date: 2013-05-13 Impact factor: 5.002